Intelligent cell-based therapies for cancer and autoimmune disorders

被引：12

作者：

Chen, Rui ^{[1
]}

Jing, Ji ^{[1
]}

Siwko, Stefan ^{[1
]}

Huang, Yun ^{[2
,3
]}

Zhou, Yubin ^{[1
,3
]}

机构：

[1] Texas A&M Univ, Ctr Translat Canc Res, Inst Biosci & Technol, Houston, TX 77030 USA

[2] Texas A&M Univ, Ctr Epigenet & Dis Prevent, Inst Biosci & Technol, Houston, TX 77030 USA

[3] Texas A&M Univ, Coll Med, Dept Translat Med Sci, Houston, TX 77030 USA

来源：

CURRENT OPINION IN BIOTECHNOLOGY | 2020年 / 66卷

关键词：

T-CELLS; TARGETED THERAPY; IMMUNOTHERAPY; SWITCH;

D O I：

10.1016/j.copbio.2020.08.012

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Synthetic biology, when combined with immunoengineering (designated synthetic immunology), has enabled the invention of an arsenal of genetically encoded synthetic devices and systems to reprogram cells for therapeutic purposes. The engineered intelligent cells can serve as 'living' drugs to treat a wide range of human diseases including cancer, disorders of the immune system, and infectious diseases. As the most successful example, cells of the immune system engineered with chimeric antigen receptors (CARs) have shown curative potentials for the treatment of hematological malignancies. We present herein emerging approaches of designing smart CARs to improve their safety, specificity and efficacy in cellular immunotherapy, and describe latest advances in applying CAR-engineered immune cells to target cancer and autoimmune diseases.

引用

页码：207 / 216

页数：10

共 50 条

[21] Dendritic Cell-Based Vaccines for Pancreatic Cancer and Melanoma [J].

Mule, James J. .

CANCER VACCINES, 2009, 1174 :33-40

[22] Engineering approaches for RNA-based and cell-based osteoarthritis therapies [J].

DeJulius, Carlisle R. ;

Walton, Bonnie L. ;

Colazo, Juan M. ;

d'Arcy, Richard ;

Francini, Nora ;

Brunger, Jonathan M. ;

Duvall, Craig L. .

NATURE REVIEWS RHEUMATOLOGY, 2024, 20 (02) :81-100

[23] Cell-based therapies: careful safety assessment for minimization of risk [J].

Comoli, Patrizia .

CYTOTHERAPY, 2010, 12 (06) :710-712

[24] Accelerating Diverse Cell-Based Therapies Through Scalable Design [J].

Peterman, Emma L. ;

Ploessl, Deon S. ;

Galloway, Kate E. .

ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, 2024, 15 :267-292

[25] Prospects of apoptotic cell-based therapies for transplantation and inflammatory diseases [J].

Saas, Philippe ;

Kaminski, Sandra ;

Perruche, Sylvain .

IMMUNOTHERAPY, 2013, 5 (10) :1055-1073

[26] IN VITRO POTENCY ASSAYS TO ASSESS THE FUNCTION OF CELL-BASED THERAPIES [J].

Pentakota, K. ;

Montelongo, S. ;

Beddard, R. ;

Jones, S. ;

Srinivasan, A. .

CYTOTHERAPY, 2023, 25 (06) :S202-S203

[27] Engineering cell-based therapies to interface robustly with host physiology [J].

Schwarz, Kelly A. ;

Leonard, Joshua N. .

ADVANCED DRUG DELIVERY REVIEWS, 2016, 105 :55-65

[28] Building with intent: Technologies and principles for engineering mammalian cell-based therapies to sense and respond [J].

Muldoon, Joseph J. ;

Donahue, Patrick S. ;

Dolberg, Taylor B. ;

Leonard, Joshua N. .

CURRENT OPINION IN BIOMEDICAL ENGINEERING, 2017, 4 :127-133

[29] Gene-modified, cell-based therapies-an overview [J].

Powell, Allison B. ;

Williams, Kiara ;

Cruz, Conrad Russelly .

CYTOTHERAPY, 2016, 18 (11) :1351-1359

[30] Vector Strategies to Actualize B Cell-Based Gene Therapies [J].

Jeske, Amanda M. ;

Boucher, Paul ;

Curiel, David T. ;

Voss, James E. .

JOURNAL OF IMMUNOLOGY, 2021, 207 (03) :755-764

← 1 2 3 4 5 →